Connect with us

Press Releases

Euclid Vision Names Dr. Zohra Fadli as Global Head of R&D and Clinical Affairs

The vision care veteran’s appointment to the top R&D role is a reflection of Euclid’s ongoing commitment to innovation.

mm

Published

on

Zohra Fadli

Zohra Fadli

(PRESS RELEASE) STERLING, VA — Euclid Vision Corp., a global leader in advanced orthokeratology and proactive myopia management initiatives, announces the appointment of Zohra Fadli, Ph.D, to the position of vice president of research and development & clinical affairs. Dr. Fadli brings decades of experience in medical device technology and vision care to her new role at Euclid, including an extensive history in delivering breakthrough ophthalmic contact lenses.

For close to 20 years, Dr. Fadli held global leadership roles in Johnson and Johnson’s (J&J) medical technology divisions. She led the J&J Vision Care Light Management Portfolio, launching a first of its kind light adaptive photochromic contact lens which was named by Time magazine as one of the best inventions in 2018.

Dr. Fadli also led J&J’s core contact lens business including sphere daily disposable, reusable, and lens care where she played an integral role in setting up the innovation, pipeline, and development of J&J’s first monthly silicone hydrogel reusable contact lens. Dr. Fadli expanded her responsibilities to lead J&J Vision care Specialty Growth Business including Myopia Progression platform, Presbyopia, and Beauty Platforms. She also pioneered J&J vision care global evidence generation strategy aimed to generate best in class clinical and technical scientific evidence in support of new product innovations. Finally, Dr. Fadli also lead the R&D strategy and operations team for J&J orthopedic surgical franchise. Dr. Fadli holds a PhD in Medical Bioengineering from Université Paris 13, France

Dr. Fadli’s timely appointment to the R&D role is a key step in Euclid’s continued expansion. Euclid recently acquired the scleral contact lens pioneer, Visionary Optics; and prior to that introduced Euclid MAX — Euclid’s newest Ortho-K lens that has outstanding material characteristics, providing excellent wettability, oxygen permeability, and lens stability. Euclid’s ongoing commitment to innovation and Dr. Fadli’s involvement in the development of groundbreaking innovation across the vision care spectrum suggest exciting times ahead for the company.

Commenting on the appointment, Joseph Boorady, Euclid president and CEO said, “We are excited to bring Dr. Fadli on board at this pivotal time in Euclid’s evolution. Having market leading technologies in two of the fastest growing specialty contact lens markets — Ortho-K and scleral lenses—positions Euclid to best serve our customers today; and having Dr. Fadli heading up R&D, positions us to anticipate and satisfy patient needs tomorrow and in the coming years.”

Advertisement

SPONSORED VIDEO

SPONSORED BY VARILUX

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular